期刊文献+

SN50对大鼠视网膜缺血再灌注损伤的保护作用

Protective effects of SN50 on retinal ischemia reperfusion injury in rats
在线阅读 下载PDF
导出
摘要 目的探讨核因子-κB(nuclear factor-κB,NF-κB)活性抑制剂SN50对大鼠视网膜缺血再灌注损伤(retinal ischemical reperfusion injury,RIRI)的保护作用。方法 27只成年雄性SD大鼠随机分为正常对照组、RIRI组、RIRI+SN50组,每组9只,建立RIRI动物模型,RIRI后6h、24h、72hHE染色观察大鼠视网膜病理变化,免疫组织化学检测NF-κB的表达,实时定量PCR检测TNF-α的表达。结果 RIRI组RIRI 6h后视网膜出现组织轻度水肿,少量细胞变性,随着时间的延长,视网膜的损伤逐渐加重;RIRI+SN50组视网膜的损伤明显减轻。RIRI后6h视网膜上可见NF-κB阳性表达,经过SN50注射处理后,NF-κB的阳性表达在RIRI后24h明显减弱;经过SN50注射处理后,与RIRI组比较,24h后视网膜的TNF-α表达差异有统计学意义(P<0.05)。结论 SN50对RIRI具有保护作用。 Objective To investigate the protective effects of nuclear factor-κB (NF-κB) inhibitor SN50 on retinal ischemia reperfusion injury (RIRI) in rats. Methods TwenW-seven male SD rats were randomly divided into the normal control group, RIRI group and RIRI + SN50 group ,9 rats in each group. RIRI models were established in rats of RIRI group and RIRI + SN50 group. Pathological changes of rat retina were observed at 6 hours,24 hours and 72 hours after RIRI,NF-κB expression sites were detected by immunohistochemistry, and the expression of TNF-α were detected by real-time PCR. Results At 5 hours after RIRI, the retinal tissue was edema slightly, a small amount of cells were degeneration. With the extension of rime,the retinal injury aggravated gradually. However, after injection of SN50, the retinal injury reduced significantly. The positive expression of NF-κB was observed in retina at 5 hours after RIRI. The positive expression of NF-κB significantly decreased after injection of SN50 at 24 hours after RIRI. Compared with RIRI group, the difference of TNF-α expression in RIRI + SN50 group were statistically significant (P 〈 0.05 ). Conclusion SN50 have the protective effects on RIRI.
出处 《眼科新进展》 CAS 北大核心 2014年第9期805-808,共4页 Recent Advances in Ophthalmology
基金 国家自然科学基金项目(编号:81200719)~~
关键词 缺血再灌注 SN50 核因子-ΚB TNF-Α 视网膜 ischemia reperfusion SNS0 nuclear factor-κB TNF- α retina
  • 相关文献

参考文献13

  • 1Blair NP, Baker DS, Rhode JP, Solomon M. Vitreoperfusion: A new approach to ocular ischemia [ J ]. Arch Ophthcamol, 1989. 107(3) :417-423.
  • 2Tsujikawa A, Ogura Y, Hiroshiba N, Miyamoto K, Kiryu J, Tojo S J, et ca. Refmal ischemia reperfusion injury attenuated by bloc- king of adhesion molecules of vascular endotheliu[ J]. hoest Ophthmol Vis Sci, 1999,40 ( 6 ) : 1183-1190.
  • 3Dvoriantehikova G, BrambiUa R, Agudelo C, Hemandez E, Be- rhea JR, Shestopalov VI, et ca. Inactivation of Astrogiial NF-Kb promotes survival of retinal neurons following ischemic injury [ J ]. Eur d Neur,2009,30 ( 2 ) : 175-185.
  • 4Neville NO, Robert JC, John PM. Retinal ischemia: mechanisms of damage and potential therapeutic strategies [ J]. Pvg Reti Eye Res ,2004,23 (1 ) :91-147.
  • 5Chen F, Castranova V, Shi X, Demers LM. New insiglit into the role of nuclear factor-KB,a ubiquous transcription factor in the initiation of diseases[ J]. J Clin Clwm, 1999,45( 1 ) :7-17.
  • 6乔梁,王汉东.Nrf2通路在创伤性脑损伤中保护作用的研究进展[J].医学研究生学报,2012,25(4):422-426. 被引量:8
  • 7谢睿,李全朋,缪林.炎症性肠病免疫发病机制研究进展[J].医学研究生学报,2013,26(2):206-210. 被引量:45
  • 8Liu T,McDonnell PC. Tumor necrosis factor expression in is- chemic neurons [ J ]. Stroke, 1994,25 ( 7 ) : 1481-1488.
  • 9Barnes PJ, Karin M. Nuclear factor-kB:A pivotal transcription factor in chronic inflammatory disease[ J ]. N Engl J Med, ]997, 336(15) :1066-1071.
  • 10Zhang Z, Qin X, Zhao X, Tong N, Gong Y, Zhang W, et al. Valpro- ic acid regulates antioxidant enzymes and prevents ischemia/ reperfusion injury in the rat retina [ J]. Curt Eye Res, 2012,37 ( 5 ) :429-437.

二级参考文献49

  • 1胡晓磊,赵允召.克罗恩病的血清学标记物[J].医学研究生学报,2007,20(4):426-429. 被引量:6
  • 2Barton JR, Gillon S, Ferguson A. Incidence of inflammatory bow- el disease in Scottish children between 1968 and 1983; marginal fall in ulcerative colitis, three-fold rise in Crohn's disease [ J]. Gut, 1989, 30(5) :618-622.
  • 3Sawczenko A, Sandhu BK, Logan RFA, et al. Prospective sur- vey of childhood inflammatory bowel disease in the British Isles [J]. Lancet, 2001, 357(9262):1093-1094.
  • 4Ghosh S, Panaccione R. Anti-adhesion molecule therapy for in- flammatory bowel disease [ J ]. Therap Adv Gastroenterol, 2010, 3 (4) :239-258.
  • 5Himmel ME, Hardenberg G, Piccirillo CA, et al. The role of T- regulatory cells and Toll-like receptors in the pathogenesis of hu- man inflammatory bowel disease [ J]. Immunology, 2008, 125 (2) :145-153.
  • 6Dalai SR, Kwon JH. The role of MicroRNA in inflammatory bowel disease[J]. Gastroenterol Hepatol( NY), 2010, 6( 11 ) :714-722.
  • 7Hamza T, Barnett JB, Li B. Interleukin 12 a key immunoregula- tory cytokine in infection applications[ J]. Int J Mol Sci, 2010, 11 (3) :789-806.
  • 8Yamaguchi Y, Takahashi H, Satoh T, et al. Natural killer cells control a T-helper 1 response in patients with Behcet's disease [J]. Arthritis Res Ther, 2010, 12(3) :R80.
  • 9Neurath MF, Finotto S, Glimcher LH. The role of Th1/Th2 polarization in mucosal immunity [ J]. Nat Med, 2002, 8 (6) :567-573.
  • 10Fuss IJ, Heller F, Boirivant M, et al. Nonclassical CDld-re- stricted NK T ceils that produce IL-13 characterize an atypical Th2 response in ulcerative colitis[ J]. J Clin Invest, 2004, 113 (10) :1490-1497.

共引文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部